Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.51M Buy
21,300
+20,900
+5,225% +$7.45M ﹤0.01% 1011
2025
Q4
$131K Buy
+400
New +$127K ﹤0.01% 2755
2025
Q2
Sell
-3,200
Closed -$991K 3016
2025
Q1
$991K Sell
3,200
-77,400
-96% -$22.9M ﹤0.01% 1754
2024
Q4
$20.9M Buy
80,600
+32,600
+68% +$9.67M 0.01% 720
2024
Q3
$15.4M Hold
48,000
0.01% 802
2024
Q2
$15M Sell
48,000
-14,600
-23% -$4.29M 0.01% 754
2024
Q1
$17.8M Buy
62,600
+18,700
+43% +$5.47M 0.01% 724
2023
Q4
$12.6M Buy
43,900
+33,300
+314% +$9.07M 0.01% 808
2023
Q3
$2.85M Hold
10,600
﹤0.01% 1308
2023
Q2
$2.35M Sell
10,600
-6,100
-37% -$1.42M ﹤0.01% 1379
2023
Q1
$4.01M Sell
16,700
-26,600
-61% -$6.53M ﹤0.01% 1202
2022
Q4
$11.3M Sell
43,300
-2,300
-5% -$617K 0.01% 893
2022
Q3
$10.4M Buy
45,600
+3,200
+8% +$776K 0.02% 851
2022
Q2
$10.3M Buy
42,400
+14,100
+50% +$3.46M 0.01% 879
2022
Q1
$6.91M Buy
28,300
+20,300
+254% +$4.66M 0.01% 1060
2021
Q4
$1.81M Buy
+8,000
New +$1.69M ﹤0.01% 1742
2021
Q2
Sell
-6,500
Closed -$1.61M 2923
2021
Q1
$1.61M Sell
6,500
-15,500
-70% -$3.7M ﹤0.01% 1383
2020
Q4
$5.01M Buy
22,000
+13,300
+153% +$3.07M 0.01% 1019
2020
Q3
$2.21M Buy
+8,700
New +$2.16M ﹤0.01% 1238
2020
Q2
Sell
-41,300
Closed -$8.41M 2643
2020
Q1
$8.41M Sell
41,300
-43,800
-51% -$9.57M 0.02% 651
2019
Q4
$20.4M Buy
85,100
+17,500
+26% +$3.86M 0.04% 511
2019
Q3
$13.1M Hold
67,600
0.02% 715
2019
Q2
$12.5M Buy
67,600
+12,700
+23% +$2.27M 0.02% 724
2019
Q1
$10.4M Sell
54,900
-75,700
-58% -$14.5M 0.02% 785
2018
Q4
$25.4M Buy
130,600
+20,600
+19% +$4.02M 0.05% 414
2018
Q3
$22.8M Buy
110,000
+12,200
+12% +$2.4M 0.04% 502
2018
Q2
$18.1M Sell
97,800
-41,500
-30% -$7.34M 0.03% 529
2018
Q1
$23.7M Buy
139,300
+134,500
+2,802% +$24.7M 0.04% 477
2017
Q4
$835K Sell
4,800
-222,100
-98% -$39.3M ﹤0.01% 1346
2017
Q3
$42.3M Buy
226,900
+39,500
+21% +$7M 0.07% 273
2017
Q2
$32.3M Buy
187,400
+107,500
+135% +$17.5M 0.06% 339
2017
Q1
$13.2M Buy
79,900
+23,600
+42% +$3.92M 0.03% 617
2016
Q4
$8.23M Sell
56,300
-20,000
-26% -$3.01M 0.02% 785
2016
Q3
$12.7M Buy
76,300
+32,900
+76% +$5.56M 0.03% 585
2016
Q2
$6.6M Sell
43,400
-136,100
-76% -$21.2M 0.02% 815
2016
Q1
$26.9M Buy
179,500
+148,400
+477% +$22M 0.08% 305
2015
Q4
$5.05M Buy
31,100
+22,100
+246% +$3.47M 0.01% 937
2015
Q3
$1.25M Sell
9,000
-63,884
-88% -$10.1M ﹤0.01% 1175
2015
Q2
$11.2M Buy
72,884
+25,684
+54% +$4.11M 0.02% 595
2015
Q1
$7.54M Buy
47,200
+18,300
+63% +$2.88M 0.01% 773
2014
Q4
$4.6M Buy
28,900
+23,600
+445% +$3.68M 0.01% 922
2014
Q3
$744K Buy
5,300
+2,700
+104% +$353K ﹤0.01% 1387
2014
Q2
$308K Sell
2,600
-8,800
-77% -$1.02M ﹤0.01% 1598
2014
Q1
$1.41M Sell
11,400
-156,600
-93% -$19M ﹤0.01% 1157
2013
Q4
$19.2M Buy
168,000
+42,600
+34% +$4.85M 0.05% 420
2013
Q3
$14M Buy
+125,400
New +$13.6M 0.04% 502

Other funds holding AMGN

HSBC Holdings's AMGN Position: Q1 2026 in Review

HSBC Holdings reduced its Amgen (AMGN) stake by 12% in Q1 2026, selling an estimated $66.3M and leaving 1,351,347 shares worth $476M. The position accounts for 0.25% of the portfolio, ranked #71.

HSBC Holdings first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $590M in Q2 2024. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • HSBC Holdings held 1,351,347 shares of Amgen worth $476M as of Q1 2026.
  • HSBC Holdings sold 185,904 Amgen shares in Q1 2026, an estimated $66.3M.
  • Amgen made up 0.25% of HSBC Holdings's portfolio in Q1 2026, its #71 holding.
  • HSBC Holdings first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • HSBC Holdings's Amgen position peaked at $590M in Q2 2024.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.